The global transdermal drug delivery systems market size was US$ 55100.33 million in 2021. The global transdermal drug delivery systems market size is forecast to reach US$ 88,422.40 million by 2030, growing at a compound annual growth rate (CAGR) of 5% during the forecast period from 2021 to 2030.
Request To Download Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC902
The transdermal drug delivery system (TDDS) belongs to the controlled drug delivery category, which involves predetermined and controlled drug delivery through the skin. It can help treat various diseases such as cardiovascular disorders, central nervous system disorders, etc. In addition to scopolamine (for motion sickness), nicotine (for quitting smoking), nitroglycerine (for angina), and lidocaine for treatment of shingles (herpes zoster), skin patches are also available. They offer many advantages, such as prolonged therapeutic effects, reduced side effects, improved bioavailability, better compliance among patients, and easy termination of drug therapy. The three main routes of drug penetration are the appendageal, transcellular, and intercellular routes.
Factors Influencing Market Growth
Rising cases of chronic diseases, which decrease the potency of conventional drug delivery systems such as oral drugs due to first-pass hepatic metabolism, are driving the global market.
Increasing advancements in the field, such as the development of new adhesives, penetration enhancers, and molecular absorption enhancers, are forecast to contribute to the market growth. This development could increase the skin’s permeability, allowing for a wider range of drugs to be delivered via transdermal routes.
Continuing R&D and soaring acceptance of these devices will propel the growth of the global transdermal drug delivery system market.
Patients’ desire for pain-free drug administration has led to a significant increase in the adoption rate of adhesive skin patches that administer drugs, expected to increase the market’s growth potential.
Impact Analysis of COVID-19
Due to the COVID-19 outbreak, the market for transdermal drug delivery systems experienced a period of slowed growth. The COVID-19 pandemic delayed a number of elective procedures, while the COVID-19 pandemic-affected patients had the utmost priority. Aside from this, several other factors had further affected the healthcare system, such as the lockdown-related restrictions, patients’ reluctance to visit hospitals and clinics, and the temporary closing of manufacturing companies.
Regional Insights
The Asia Pacific region is forecast to grow at a significant rate in the market during the forecast period. As a result of rising chronic and acute disease prevalence, growing awareness about proper disease management, and increasing demand for technologically advanced devices and drugs, the market is growing. In addition, increasing government support for the treatment and management of diverse diseases is likely to spur market growth in the region.
Get a Sample PDF copy of the report @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC902
Leading Competitors
The leading prominent companies profiled in the global transdermal drug delivery systems market are:
Viatris Incorporated
Bayer AG
Boehringer Ingelheim GmbH
Endo International plc
GlaxoSmithKline plc
Johnson & Johnson
Novartis AG
Purdue Pharma L.P.
Altaris
Hisamitsu Pharmaceutical Co. Incorporated
Other Prominent Players
The report furnishes an intricate comprehension of each segment, delivering potential estimations for principal applications and insights into emerging prospects. Every regional market is meticulously scrutinized to ascertain its potential for growth, development, and demand in the forthcoming years.
As of the end of 2022, the Transdermal Drug Delivery Systems industry experienced notable growth in its workforce. Starting in January, employment within the Transdermal Drug Delivery Systems sector exceeded its pre-COVID levels, resulting in an expansion of payrolls by over 15,000 employees throughout the course of the year. The global Transdermal Drug Delivery Systems output demonstrated a remarkable increase of 5.2% during 2021, primarily attributed to a widespread economic upswing and a surge in demand for commodities. However, the momentum shifted in 2022, with the global industrial sector’s production contracting. This reversal followed a robust expansion in 2021, fueled by altered consumer spending patterns and substantial fiscal support.
Forecasts indicate that the global Transdermal Drug Delivery Systems output is set to rise by approximately 2.9% in 2023. This projection is underpinned by the gradual recovery of production in Western Europe from its previous troughs, as well as a rebound in output across the Asia/Pacific region. Maintaining its dominant position, China, accounting for nearly 45% of the global Transdermal Drug Delivery Systems market, remains both its largest producer and consumer. Remarkably, China’s market share has surged since 2010, when it stood at around 26%. This ascent has led to a substantial contribution to the nation’s GDP. Notably excelling as a top exporter, China leads in various sectors, including silicon, PVC, and several specific segments of the Transdermal Drug Delivery Systems market.
Scope of the Report
The global transdermal drug delivery systems market segmentation focuses on Delivery System Type, Application, and Region.
Segmentation based on Delivery System Type
Passive
Active
Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report ) @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC902
Segmentation based on Application
Analgesics
Hormone Replacement Therapies
Hypertension
Motion Sickness
Smoking Cessation
Others
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Get The Insights You Need By Customizing Your Report To Fit Your Unique Needs And Goals:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC902
Table of Contents:
Chapter 1: Introduction to the Global Transdermal Drug Delivery Systems Industry
Chapter 3: Dynamics of the Market
Chapter 4: Profiles of Leading Companies
Chapter 5: Competition in the Global Transdermal Drug Delivery Systems Market among Players
Chapter 6: Market Size across Global Regions
Chapter 7: Application Segments in the Global Market
Chapter 8: Segment Analysis of the Global Transdermal Drug Delivery Systems Industry
Chapter 9: Market Chain, Sourcing Strategies, and Downstream Buyers
Chapter 10: Strategies and Key Policies by Distributors/Suppliers/Traders
Chapter 11: In-depth Analysis of Key Marketing Strategies by Market Vendors
Chapter 12: Evaluation of Market Impact Factors
Chapter 13: Forecasted Global Transdermal Drug Delivery Systems Market Size (2023-2031)
Reasons to Acquire This Report
(A) This research imparts invaluable insights tailored for senior management, policymakers, industry professionals, product innovators, sales executives, and stakeholders within the market. It equips them with the information needed to make well-informed decisions and craft effective strategies.
(B) The report delivers a comprehensive analysis of global, regional, and country-level Transdermal Drug Delivery Systems market revenues, extending projections until 2030. This dataset empowers companies to gauge their market presence, recognize avenues for growth, and explore emerging markets.
(C) Through meticulous segmentation of the Transdermal Drug Delivery Systems market encompassing types, applications, technologies, and end-uses, this study empowers leaders to blueprint their products and allocate resources based on the projected growth trajectories of each segment.
(D) Investors stand to gain from the market analysis by gaining insights into market scope, positioning, key drivers, challenges, limitations, expansion prospects, and potential risks. Armed with this knowledge, they can make well-considered investment choices.
(E) The report conducts an intricate analysis of competitors, unraveling their pivotal strategies and market positioning. This intelligence equips businesses with a profound understanding of the competitive landscape, enabling them to chart their own strategies accordingly.
(F) The study facilitates the assessment of Transdermal Drug Delivery Systems business projections delineated by region, key countries, and prominent companies, bestowing invaluable information for investment strategizing and decision-making.
Why is our study consequential?
Our study holds paramount importance for various reasons, a few of which include:
* Assisting businesses in gauging the viability of new or existing products or services.
* Facilitating business enterprises in the identification and cultivation of novel market segments.
* Providing a preemptive understanding of consumer demand prior to introducing new products, services, or features.
* Enhancing the overall efficacy of marketing, advertising, and promotional initiatives.
* Analyzing market trends to aid businesses in devising adaptive strategies.
* Guiding businesses in the optimal placement of their products.
Access Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC902
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.
Contact Information:
Email:[email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, United States
Telephone: +1 888 212 3539 (US – Toll-Free)
For more information and to explore their offerings, visit their website at:https://www.reportocean.com/
